Invention Grant
- Patent Title: Methods and compositions for in vivo gene editing based cell-type-specific cellular engineering
-
Application No.: US16845009Application Date: 2020-04-09
-
Publication No.: US11702644B2Publication Date: 2023-07-18
- Inventor: Yuki Oka , Allan-Hermann Pool
- Applicant: California Institute of Technology
- Applicant Address: US CA Pasadena
- Assignee: California Institute of Technology
- Current Assignee: California Institute of Technology
- Current Assignee Address: US CA Pasadena
- Agency: Sheppard, Mullin, Richter & Hampton LLP
- Main IPC: C12N9/22
- IPC: C12N9/22 ; A61K9/00 ; A61K35/12 ; A61K48/00 ; C12N15/11 ; C12N15/86 ; C12N15/90 ; A61K38/00 ; A61P25/04 ; A61P25/28

Abstract:
Disclosed herein include methods and compositions for incorporating an effector gene into the genome of a cell. The method can comprise introducing into a cell a donor nucleic acid comprising a recognition site, a splice acceptor site, a self-cleaving peptide sequence, an effector gene, and an optional transcript stabilization element. The donor nucleic acid can be incorporated into the intron of a target gene differentially expressed in a unique cell type and/or in a cell during a unique cell state via non-homologous end joining (NHEJ)-dependent DNA repair. There are also provided, in some embodiments, methods and compositions for treating a disease or disorder in a subject.
Public/Granted literature
- US20200347369A1 METHODS AND COMPOSITIONS FOR IN VIVO GENE EDITING BASED CELL-TYPE-SPECIFIC CELLULAR ENGINEERING Public/Granted day:2020-11-05
Information query